Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SEER - Seer Inc - Ordinary Shares - Class A


IEX Last Trade
1.685
-0.025   -1.484%

Share volume: 153,118
Last Updated: Fri 30 Aug 2024 09:59:45 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$1.71
-0.03
-1.46%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
20%
Profitability 0%
Dept financing 3%
Liquidity 75%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
4.35%
1 Month
-14.72%
3 Months
-5.08%
6 Months
-6.67%
1 Year
-34.88%
2 Year
-81.92%
Key data
Stock price
$1.68
P/E Ratio 
-1.17
DAY RANGE
N/A - N/A
EPS 
-$1.28
52 WEEK RANGE
$1.46 - $2.70
52 WEEK CHANGE
-$0.38
MARKET CAP 
96.405 M
YIELD 
N/A
SHARES OUTSTANDING 
57.384 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
1.26
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$370,763
AVERAGE 30 VOLUME 
$309,514
Company detail
CEO:
Region: US
Website: seer.bio
Employees: 157
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

seer, inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. the company develops proteograph product suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. it intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. seer, inc. has a collaboration program agreement with discovery life sciences, llc; and commercial agreements with bruker scientific llc and thermo electron north america llc. the company was formerly known as seer biosciences, inc. and changed its name to seer, inc. in july 2018. seer, inc. was incorporated in 2017 and is headquartered in redwood

Recent news